← All trials
NCT04733742
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- Dec 1, 2025
- Completion date
- Dec 1, 2025
- First posted
- Feb 2, 2021
- Last posted
- Sep 16, 2021
- Enrollment
- 586
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- People's Liberation Army of ChinaLead sponsor
- People's Liberation Army of ChinaReponsible party - principal investigator
- Huazhong University of Science and TechnologyCollaborator
- University of California, Los AngelesOverall official - principal investigator
- People's Liberation Army of ChinaCollaborator
- Maoming city hospital of Traditional Chinese MedicineCollaborator
- Emory UniversityOverall official - principal investigator
- People's Liberation Army of ChinaOverall official - principal investigator
- Jilin UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.